Multiple Myeloma Research

Paul Voss Thanks to a new three-medication therapy for multiple myeloma, Paul Voss feels good and looks ahead to many more rounds of golf.

University of Chicago physicians and scientists are at the forefront of basic and clinical research in multiple myeloma. Our program works collaboratively with basic scientists at the University of Chicago Comprehensive Cancer Center to investigate and develop new therapeutics for multiple myeloma. In addition, members of the multiple myeloma team at the Medical Center are active participants in the Multiple Myeloma Research Consortium (MMRC) – an association of 16 academic medical centers dedicated to accelerating research on multiple myeloma, creating new treatment protocols, and bringing the most promising therapies to patients in a timely manner.

Participate in a Clinical Trial

View a list of multiple myeloma clinical trials currently recruiting participants at the University of Chicago Comprehensive Cancer Center.